---
layout: indicator
sdg_goal: '3'
target_id: '3.b'
permalink: /3-b-3/
published: true
target: >-
  3.b Support the research and development of vaccines and medicines for the communicable and nonâ€‘communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement
  and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
indicator: 3.b.3
indicator_name: 3.b.3 Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis

un_designated_tier: 3
un_custodian_agency: World Health Organisation (WHO)
goal_meta_link: https://unstats.un.org/sdgs/files/metadata-compilation/Metadata-Goal-3.pdf
goal_meta_link_text: United Nations Sustainable Development Goals Metadata (PDF 866 KB)
data_non_statistical: false
graph_type: line
data_keywords:  
indicator_sort_order: 0250
comments_limitations: >-
  Data follows the UN specification for this indicator.This, or part of this, indicator is awaiting the development of internationally established methodology and standards (classified by the UN as tier 3).This indicator has not been identified in collaboration with topic experts.

source_active_1: true
source_active_2: true
source_active_3: true
source_active_4: true
source_active_5: true
source_active_6: true
---
